Kemal Payza

2.4k total citations
40 papers, 1.9k citations indexed

About

Kemal Payza is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Kemal Payza has authored 40 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Cellular and Molecular Neuroscience, 27 papers in Molecular Biology and 4 papers in Physiology. Recurrent topics in Kemal Payza's work include Neuropeptides and Animal Physiology (27 papers), Receptor Mechanisms and Signaling (20 papers) and Chemical Synthesis and Analysis (9 papers). Kemal Payza is often cited by papers focused on Neuropeptides and Animal Physiology (27 papers), Receptor Mechanisms and Signaling (20 papers) and Chemical Synthesis and Analysis (9 papers). Kemal Payza collaborates with scholars based in United States, Canada and United Kingdom. Kemal Payza's co-authors include Chantévy Pou, Ralf Schmidt, Maryse Labarre, Claude Godbout, Paola Lembo, Dajan O’Donnell, Manon Pelletier, Philippe Walker, W. A. Brown and Eric Grazzini and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Neuroscience.

In The Last Decade

Kemal Payza

40 papers receiving 1.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Kemal Payza 1.1k 982 332 308 228 40 1.9k
Jean‐Claude Beauvillain 876 0.8× 1.0k 1.0× 509 1.5× 614 2.0× 116 0.5× 72 2.9k
E Weber 1.8k 1.6× 1.6k 1.6× 329 1.0× 122 0.4× 101 0.4× 43 2.4k
James E. Garrett 559 0.5× 2.1k 2.1× 248 0.7× 127 0.4× 63 0.3× 51 3.1k
Hisashi Iwaasa 578 0.5× 728 0.7× 319 1.0× 966 3.1× 204 0.9× 55 2.1k
Amanda Pellegrino de Iraldi 1.3k 1.1× 1.2k 1.2× 350 1.1× 227 0.7× 66 0.3× 66 2.4k
Rita Raddatz 885 0.8× 1.0k 1.1× 179 0.5× 142 0.5× 186 0.8× 42 1.7k
Katharine Herrick‐Davis 1.4k 1.3× 1.7k 1.7× 127 0.4× 70 0.2× 208 0.9× 49 2.4k
D.G. Smyth 2.6k 2.3× 2.4k 2.4× 589 1.8× 528 1.7× 66 0.3× 77 3.7k
John Salon 2.1k 1.9× 2.2k 2.3× 173 0.5× 188 0.6× 36 0.2× 24 3.1k
A. Ánastasi 1.3k 1.1× 1.1k 1.2× 223 0.7× 189 0.6× 96 0.4× 40 2.4k

Countries citing papers authored by Kemal Payza

Since Specialization
Citations

This map shows the geographic impact of Kemal Payza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kemal Payza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kemal Payza more than expected).

Fields of papers citing papers by Kemal Payza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kemal Payza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kemal Payza. The network helps show where Kemal Payza may publish in the future.

Co-authorship network of co-authors of Kemal Payza

This figure shows the co-authorship network connecting the top 25 collaborators of Kemal Payza. A scholar is included among the top collaborators of Kemal Payza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kemal Payza. Kemal Payza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cantin, Louis‐David, Malken Bayrakdarian, Eric Grazzini, et al.. (2012). Discovery of P2X3 selective antagonists for the treatment of chronic pain. Bioorganic & Medicinal Chemistry Letters. 22(7). 2565–2571. 26 indexed citations
2.
Liu, Jay, Kemal Payza, Jian Huang, et al.. (2009). Discovery and Pharmacological Characterization of a Small-Molecule Antagonist at Neuromedin U Receptor NMUR2. Journal of Pharmacology and Experimental Therapeutics. 330(1). 268–275. 14 indexed citations
3.
Hudzik, Thomas J., et al.. (2000). Antiparkinson potential of δ-opioid receptor agonists. European Journal of Pharmacology. 396(2-3). 101–107. 32 indexed citations
4.
Pagé, Daniel, Andrew McClory, Joanne Butterworth, et al.. (2000). Novel Dmt-Tic dipeptide analogues as selective delta-opioid receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 10(2). 167–170. 18 indexed citations
5.
Labarre, Maryse, Joanne Butterworth, Stéphane St-Onge, et al.. (2000). Inverse agonism by Dmt–Tic analogues and HS 378, a naltrindole analogue. European Journal of Pharmacology. 406(1). R1–R3. 24 indexed citations
6.
Fraser, Graeme L., Maryse Labarre, Claude Godbout, et al.. (1999). Characterization of [125I]AR-M100613, a high-affinity radioligand for δ opioid receptors. Peptides. 20(11). 1327–1335. 9 indexed citations
7.
Lembo, Paola, Eric Grazzini, Douglas A. Hubatsch, et al.. (1999). The receptor for the orexigenic peptide melanin-concentrating hormone is a G-protein-coupled receptor. Nature Cell Biology. 1(5). 267–271. 212 indexed citations
8.
O’Donnell, Dajan, Huy Khang Vu, Kemal Payza, et al.. (1998). Cloning and Characterization of a cDNA Encoding a Novel Subtype of Rat Thyrotropin-releasing Hormone Receptor. Journal of Biological Chemistry. 273(48). 32281–32287. 111 indexed citations
10.
Payza, Kemal, et al.. (1996). Receptor inactivation by dye-neuropeptide conjugates: 1. The synthesis of Cys-containing dye-neuropeptide conjugates. Peptides. 17(6). 991–994. 8 indexed citations
11.
Malin, David H., John R. Lake, David A. Smith, et al.. (1995). Subcutaneous injection of an analog of neuropeptide FF prevents naloxone-precipitated morphine abstinence syndrome. Drug and Alcohol Dependence. 40(1). 37–42. 30 indexed citations
12.
Chin, G. J., Kemal Payza, David A. Price, Michael J. Greenberg, & K. E. Doble. (1994). Characterization and Solubilization of the FMRFamide Receptor of Squid. Biological Bulletin. 187(2). 185–199. 41 indexed citations
13.
Malin, David H., et al.. (1993). Enhanced antiopiate activity and enzyme resistance in peptidomimetics of FMRFamide containing. Peptides. 14(4). 731–734. 26 indexed citations
14.
Payza, Kemal & Hsiu‐Ying T. Yang. (1993). Modulation of Neuropeptide FF Receptors by Guanine Nucleotides and Cations in Membranes of Rat Brain and Spinal Cord. Journal of Neurochemistry. 60(5). 1894–1899. 31 indexed citations
15.
Malin, David H., et al.. (1993). Enhanced antiopiate activity in peptidomimetics of FMRFamide containing Z-2,3-methanomethionine. Peptides. 14(1). 47–51. 27 indexed citations
16.
Fatatis, Alessandro, Lynne A. Holtzclaw, Kemal Payza, & James T. Russell. (1992). Secretion from rat neurohypophysial nerve terminals (neurosecretosomes) rapidly inactivates despite continued elevation of intracellular Ca2+. Brain Research. 574(1-2). 33–41. 11 indexed citations
17.
Lake, John R., et al.. (1992). Analog of neuropeptide FF attenuates morphine tolerance. Neuroscience Letters. 146(2). 203–206. 44 indexed citations
18.
Payza, Kemal & James T. Russell. (1991). Sodium inhibits hormone release and stimulates calcium efflux from isolated nerve endings of the rat neurohypophysis. Cellular and Molecular Neurobiology. 11(3). 321–331. 5 indexed citations
19.
Payza, Kemal, Michael J. Greenberg, & David A. Price. (1989). Further characterization of Helix FMRFamide receptors: Kinetics, tissue distribution, and interactions with the endogenous heptapeptides. Peptides. 10(3). 657–661. 20 indexed citations
20.
Payza, Kemal. (1987). FMRFamide receptors in Helix aspersa. Peptides. 8(6). 1065–1074. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026